• Trial of T-Cells Genetically-Engineered to Express an Anti-CD19 Chimeric Antigen Receptor Show Promise as NewTtreatment Approach for B-cell Malignancies
• New Finding Pinpoints a Critical Gene Involved in Melanoma Growth and Provides a Framework for Discovering Ways to Tackle Cancer Drug Resistance
• Personalized Cancer Therapy Requires New Strategies for Cancer Drug Development
• New Discovery Halts Breast Cancer Stem Cells – Suggesting A New Drug Therapy Target
• New Therapy Provide Significant Survival Benefit In Second-line Metastatic Hormone-refractory Prostate Cancer (mHRPC)
• Cancer Tutorial: Introduction to Drug Resistance
• Scientists Unveil Genetic Code for Skin and Lung Cancer

• Erlotinib is the First Personalized Medicine Approved for the Initial Treatment of People with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
• Angelina Jolie: A Difficult Choice and A Courageous Decision
• Enzastaurin Does Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma Study
• Study Evaluates Treatment of High Dose Aldesleukin + Vemurafenib in Patients with Metastatic Melanoma
• New Diagnostic Test Effectively Predicts Rapid Metastatic Prostate Cancer (RMD) - Outperforms Existing Tools
• UK Charity Calls for More Attention and Awareness for Bladder Cancer
• Cryoablation Shows Promising Results in the Treatment of Breast Cancer

• Newly Identified microRNAs Could be Biomarkers for Early Diagnosis of Progression of Barrett's Esophagus and Esophageal Adenocarcinoma
• Scientific Advisory Board of Patient Advocate Organizations Disagree with Changes to Mammography Guidelines
• PD-L1 Antibody MPDL3280A is well Tolerated in Phase I Study - No Limiting Toxicities Across a Range of Cancer Types
• First Ever Estimate Reveals the Direct and Indirect Economic Burden of Cancer in Europe
• Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) Shows Prolonged Progression Free Survival in High Risk, Advanced CLL/SLL and MCL Patients
• Expense and Unaffordable Leukemia Treatment May Harm Patients
• New Drug Delivery System: Gold Nanoparticles use DNA to Deliver Doxorubicin, Improving Cancer Treatment

• cancer (603)
• Cancer (266)
• oncology (134)
• breast (110)
• ASCO (99)
• treatment (96)
• Breast (80)
• trial (80)
• chemotherapy (72)
• FDA (71)

2013

• May (12)
• April (24)
• March (34)
• February (10)
• January (21)

2012

• December (32)
• November (19)
• October (17)
• September (9)
• August (10)
• July (4)
• June (29)
• May (16)
• April (6)
• March (4)
• February (21)
• January (38)

2011

• December (47)
• November (32)
• October (21)
• September (32)
• August (18)
• July (23)
• June (83)
• May (45)
• April (54)
• March (36)
• February (62)
• January (43)

2010

• December (58)
• November (49)
• October (65)
• September (23)
• August (7)
• July (4)
• June (34)
• May (7)
• April (7)
• March (5)
• February (3)
• January (6)

2009

• December (43)
• November (42)
• October (16)
• September (15)
• July (2)
• June (4)
• May (3)
• February (1)
• January (4)

2008

• December (19)

2007

• April (1)

2005

• November (1)
• September (1)

2004

• September (1)

2001

• November (1)